InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,477.90
(
0.16%
)
US TECH 100
19,163.20
(
-0.06%
)
Dow Jones
39,127.80
(
0.04%
)
Brent Oil
84.51
(
0.38%
)
Bitcoin
60,992.96
(
-1.32%
)
Post# of 44690
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Snoop_dog

Send PM Follow Ignore
Followers 11
Posts 790
Boards Moderated 0
Alias Born 04/21/2015

Snoop_dog

Re: None

Tuesday, 09/15/2020 10:47:15 PM

Tuesday, September 15, 2020 10:47:15 PM

Post# of 44690
"Estimated Study Completion Date : September 2020" and it's Available!!
Official Title: Intravenous Aviptadil for Critical COVID-19 With Respiratory Failure
Actual Study Start Date : May 15, 2020
Estimated Primary Completion Date : August 2020
Estimated Study Completion Date : September 2020
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
InvestorsHub NewsWire

FEATURED POET Wins "Best Optical AI Solution" in 2024 AI Breakthrough Awards Program • Jun 26, 2024 10:09 AM

HealthLynked Promotes Bill Crupi to Chief Operating Officer • HLYK • Jun 26, 2024 8:00 AM

Bantec's Howco Short Term Department of Defense Contract Wins Will Exceed $1,100,000 for the current Quarter • BANT • Jun 25, 2024 10:00 AM

ECGI Holdings Targets $9.7 Billion Equestrian Apparel Market with Allon Brand Launch • ECGI • Jun 25, 2024 8:36 AM

Avant Technologies Addresses Progress on AI Supercomputer-Driven Data Centers • AVAI • Jun 25, 2024 8:00 AM

Green Leaf Innovations, Inc. Expands International Presence with New Partnership in Dubai • GRLF • Jun 24, 2024 8:30 AM

Start posting your company's news
Only $200 per official company press release!